Several other tumor antigens, including LUNX and B7-H3, also exhibit great potential as targeted antigens in CAR-T cell therapy because they are aberrantly expressed in lung cancer tissues, with a relatively low expression in normal tissues (118, 144). The gene discussed is CD276; the disease is lung cancer.